• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
  • Newsroom
    • Scientific Publications
    • Press Releases
    • Events
  • Partnering
  • Investors
    • Overview
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us

Shareholders Information

Shareholders Information

Equity Threshold (as of November 14, 2025)

Voting Threshold (as of November 14, 2025)

Total Number of Shares And Voting Rights

As of November 14, 2025
Total amount of share capital (EUR) 9,216,154.53
Total number of shares with single voting rights 17,140,644
Total number of shares with double voting rights 27,621,261
Total number of shares 44,761,905
Total number of voting rights 72,383,166
Total number of attributed warrants 3,856,134
Total number of shares with voting rights that could be created following the exercise of the attributed warrants 3,856,134
Total number of diluted shares (outstanding shares + warrants) 48,618,039
Total number of diluted voting rights 76,239,300

Transparency Declarations

19 Dec 2023 Fortress Investment Group LLC
28 Nov 2023 Tolefi SA
17 Nov 2023 Fortress Investment Group LLC
13 Sep 2023 Fortress Investment Group LLC
08 Sep 2023 Tolefi SA
05 Sep 2023 Fortress Investment Group LLC
17 Dec 2021 Tolefi SA
13 Dec 2021 Fortress Investment Group LLC
19 May 2021 Victory Capital Management Inc.
05 May 2021 Tolefi SA
28 Sep 2018 Victory Capital Management Inc.

Investor Contact Information:

Investors@celyad.com

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Newsroom
  • Partnering
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2026 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use